Navigation Links
Interventional Cardiologists Nico Pijls, Bernard De Bruyne to Discuss Benefits of Measuring Coronary Pressure in Improving Multivessel PCI at ESC Congress 2007
Date:8/31/2007

EBAC-Accredited Workshop Set for Sept. 3

UPPSALA, Sweden and WILMINGTON, Mass., Aug. 31 /PRNewswire/ -- Nico Pijls, M.D., Ph.D., and Bernard de Bruyne, M.D., Ph.D., will present the benefits of measuring coronary pressure, or Fractional Flow Reserve (FFR), in improving the outcomes of multivessel PCI in a workshop at the European Society of Cardiology (ESC) Congress 2007 in Vienna. The EBAC-accredited workshop, which is sponsored by Radi Medical Systems, will take place at 12:45 p.m. CEST on Monday, Sept. 3, in the Copenhagen Room in Zone 1 of the Messe Wien Conference Center.

Dr. Pijls, of the department of cardiology at Catharina Hospital in Eindhoven, the Netherlands, will cover "Assessment Of Ischaemia In The Cathlab: The Best And Easiest Way To Go." Dr. de Bruyne, with the Cardiovascular Center Aalst in Aalst, Belgium, will explore the "Diagnosis And Treatment Of Multivessel Disease: All In One." Both physicians were investigators in the DEFER study, which evaluated the appropriateness of stenting a coronary stenosis (abnormal narrowing) that appears to be angiographically significant but is not restricting blood flow enough to cause symptoms. Five-year results were published in the May 29 issue of the Journal of the American College of Cardiology.

About FFR

FFR expresses maximum achievable blood flow in a coronary artery with abnormal stenosis as a fraction of normal maximum blood flow in the absence of a stenosis. It is calculated using an interventional guidewire with a specially designed sensor built into it. Using the well established value of 0.75, FFR is 100% specific in identifying which lesions are actually causing flow restriction and can be treated. FFR also documents the exact percentage of the reduction in flow associated with each lesion.

About Radi Medical Systems AB

Radi Medical Systems AB (Radi) develops, manufactures and sells medical devices designed to improve patient care. The company's pioneering work in the field of interventional cardiology has resulted in market-leading intravascular sensors and hemostasis management and radiology devices. Radi works closely with medical practitioners to develop solutions that address clinical needs, as well as provide clinical education support. Founded in 1988, Radi employs more than 350 people globally and has representation in more than 40 countries. The company is based in Uppsala, Sweden, and maintains a U.S. headquarters in Wilmington, Mass. For more information, visit http://www.radi.se.

Media Contacts:

David Schull or Benjamin Carmichael

Russo Partners LLC

+1 212-845-4271

david.schull@russopartnersllc.com

benjamin.carmichael@russopartnersllc.com

Jim Archetto

Radi Medical Systems Inc.

+1 877-337-7234 x812

jim.archetto@radi.se


'/>"/>
SOURCE Radi Medical Systems AB
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. VC trends, company progress discussed at Mason Wells portfolio meeting
2. Rayovacs IT team discusses network security, Sarbanes-Oxley and ROI myths
3. State CIO discusses IT and government
4. Industry Veterans discuss the "next big thing"
5. Biotech Pioneer Discusses Breakthrough in Osteoporosis Treatment
6. Wisconsin Leaders Discuss Economic Development
7. Siemens health services president calls IT benefits unassailable
8. Miszewski touts benefits of IT integration
9. State criticized over BadgerNet 2 execution; some doubt benefits
10. U.S. manufacturing benefits if utilities can assist them with energy efficiency efforts
11. Sensenbrenner and USPTO Director highlight benefits of technology transfer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... ... the previously announced identification of its first three targets, it has identified a ... Amyloid beta (Aß), implicated in the development and progression of Alzheimer’s disease (AD). ...
(Date:5/4/2016)... ... May 04, 2016 , ... Proove Biosciences, Inc. , the commercial and ... McGill University . The partnership is designed to advance research in pain genetics ... patients in pain. With the new agreement, researchers at Proove Biosciences are able to ...
(Date:5/4/2016)... York , May 4, 2016 ... Transparency Market Research "Metabolomics Market - Global Industry Analysis, ... the metabolomics market is anticipated to expand at a ... USD 2,494.8 million by 2024. Metabolomics is ... metabolites, within cells, biofluids, tissues or organisms. Together, these ...
(Date:5/3/2016)... May 3, 2016 ... Drug Discovery, Gene Expression) Lab-on-a-chip (IVD & ... Institutes, Diagnostics Centers), Fabrication Technology (Microarrays, Microfluidics) ... the market is expected to reach USD ... Billion in 2015, growing at a CAGR ...
Breaking Biology Technology:
(Date:3/3/2016)... , March 3, 2016  FlexTech, a SEMI ... categories of Innovation, Research & Development, Leadership in Education, ... This is the 9 th year of the ... of companies and individuals from past years . ... on a pre-described set of criteria, by a panel ...
(Date:3/3/2016)... and DE SOTO, Kansas , March ... Detection Plus® to offer Oncimmune,s Early CDT®-Lung, a ... early detection of lung cancer Early CDT®-Lung ... and individuals. --> Early CDT®-Lung test to ... --> Oncimmune, a leader in early cancer ...
(Date:3/2/2016)... 2016 http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) ... "Global Biometrics as a Service Market 2016-2020" ... --> http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) has announced the ... a Service Market 2016-2020" report to ... and Markets ( http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) has announced ...
Breaking Biology News(10 mins):